Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

IL-17 signaling and A20: a balancing act.

Garg AV, Gaffen SL.

Cell Cycle. 2013 Nov 15;12(22):3459-60. doi: 10.4161/cc.26699. Epub 2013 Oct 8. No abstract available.

2.

The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling.

Garg AV, Ahmed M, Vallejo AN, Ma A, Gaffen SL.

Sci Signal. 2013 Jun 4;6(278):ra44. doi: 10.1126/scisignal.2003699.

3.

IL-17RC is critically required to maintain baseline A20 production to repress JNK isoform-dependent tumor-specific proliferation.

Yan C, Lei Y, Lin TJ, Hoskin DW, Ma A, Wang J.

Oncotarget. 2017 Jun 27;8(26):43153-43168. doi: 10.18632/oncotarget.17820.

4.

The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction.

Ho AW, Garg AV, Monin L, Simpson-Abelson MR, Kinner L, Gaffen SL.

PLoS One. 2013 Jul 29;8(7):e70168. doi: 10.1371/journal.pone.0070168. Print 2013.

5.

The deubiquitinase activity of A20 is dispensable for NF-κB signaling.

De A, Dainichi T, Rathinam CV, Ghosh S.

EMBO Rep. 2014 Jul;15(7):775-83. doi: 10.15252/embr.201338305. Epub 2014 May 30.

6.

A20: attractive without showing cleavage.

Verhelst K, van Loo G, Beyaert R.

EMBO Rep. 2014 Jul;15(7):734-5. doi: 10.15252/embr.201439014. Epub 2014 May 30. No abstract available.

7.

Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6.

Rong Z, Cheng L, Ren Y, Li Z, Li Y, Li X, Li H, Fu XY, Chang Z.

Cell Signal. 2007 Jul;19(7):1514-20. Epub 2007 Feb 6.

PMID:
17346928
8.

Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.

Li P, Wang Y, Turner JH.

Int Forum Allergy Rhinol. 2015 Jul;5(7):583-9. doi: 10.1002/alr.21538. Epub 2015 Apr 24.

9.

IL-17 family: cytokines, receptors and signaling.

Gu C, Wu L, Li X.

Cytokine. 2013 Nov;64(2):477-85. doi: 10.1016/j.cyto.2013.07.022. Epub 2013 Sep 3. Review.

10.

Mechanisms for regulating deubiquitinating enzymes.

Wolberger C.

Protein Sci. 2014 Apr;23(4):344-53. doi: 10.1002/pro.2415. Epub 2014 Feb 12. Review.

11.

An Overview of Interleukin-17A and Interleukin-17 Receptor A Structure, Interaction and Signaling.

Krstic J, Obradovic H, Kukolj T, Mojsilovic S, Okic-Dordevic I, Bugarski D, Santibanez JF.

Protein Pept Lett. 2015;22(7):570-8. Review.

PMID:
25990083
12.

TPL2 mediates IL-17R signaling in neuroinflammation.

Xiao Y, Sun SC.

Oncotarget. 2015 Sep 8;6(26):21789-90. No abstract available.

13.

Role of Deubiquitinating Enzymes in DNA Repair.

Kee Y, Huang TT.

Mol Cell Biol. 2015 Dec 7;36(4):524-44. doi: 10.1128/MCB.00847-15. Print 2016 Feb 15. Review.

14.

The biology of A20-like molecules.

Enesa K, Evans P.

Adv Exp Med Biol. 2014;809:33-48. Review.

PMID:
25302364
15.

IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease.

Zepp J, Wu L, Li X.

Trends Immunol. 2011 May;32(5):232-9. doi: 10.1016/j.it.2011.02.007. Epub 2011 Apr 12. Review.

16.

IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling.

Rong Z, Wang A, Li Z, Ren Y, Cheng L, Li Y, Wang Y, Ren F, Zhang X, Hu J, Chang Z.

Cell Res. 2009 Feb;19(2):208-15. doi: 10.1038/cr.2008.320.

17.

IL-17 signaling in host defense and inflammatory diseases.

Qian Y, Kang Z, Liu C, Li X.

Cell Mol Immunol. 2010 Sep;7(5):328-33. doi: 10.1038/cmi.2010.27. Epub 2010 May 31. Review.

18.

Arrestin interaction with E3 ubiquitin ligases and deubiquitinases: functional and therapeutic implications.

Shenoy SK.

Handb Exp Pharmacol. 2014;219:187-203. doi: 10.1007/978-3-642-41199-1_10.

PMID:
24292831
19.

IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail.

Ho AW, Shen F, Conti HR, Patel N, Childs EE, Peterson AC, Hernández-Santos N, Kolls JK, Kane LP, Ouyang W, Gaffen SL.

J Immunol. 2010 Jul 15;185(2):1063-70. doi: 10.4049/jimmunol.0903739. Epub 2010 Jun 16.

20.

Regulation of neuronal morphogenesis and positioning by ubiquitin-specific proteases in the cerebellum.

Anckar J, Bonni A.

PLoS One. 2015 Jan 21;10(1):e0117076. doi: 10.1371/journal.pone.0117076. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0135535. PLoS One. 2015;10(7):e0133943.

Supplemental Content

Support Center